Febuxostat for brain bleed patients managed without surgery
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if febuxostat, a medicine used for gout, can help people recover from a brain bleed (intracranial hemorrhage) when surgery is not needed. It may reduce inflammation and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a brain bleed confirmed by a CT scan.
- Your doctors are treating the bleed without surgery (conservative management).
- You do not have severe kidney or liver problems.
- You are not pregnant or breastfeeding.
- You are not allergic to febuxostat.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the statin drug atorvastatin can help people recover from a type of stroke called a brain bleed. It is for adults who have a moderate-sized bleed in the upper part of the brain and can start taking the drug within 48 hours of symptoms.
This trial tests a new medicine called tigulixostat against febuxostat, a standard gout treatment, to see which works better at lowering uric acid levels. You may qualify if you have gout with high uric acid and have not had a gout flare in the last month.
This trial tests if adding febuxostat to your usual mesalamine treatment can help improve mild to moderate ulcerative colitis. It's for adults with confirmed UC who are not on steroids or other immune-suppressing drugs.
This trial tests an experimental tablet (SHR4640) added to the standard gout medicine febuxostat (40 mg daily) for people whose uric acid remains too high despite febuxostat alone. The goal is to see if the combination lowers uric acid more effectively and safely.
This Phase 3 study compares starting febuxostat immediately during a gout flare versus delaying the start. It aims to see which timing helps control gout better and safely.
This trial tests if gradually lowering the dose of the gout medication febuxostat is safe for people whose gout has been well-controlled for at least 5 years. The goal is to see if a lower dose can still keep uric acid levels in a healthy range.
Hear when a new Intracranial Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.